Cargando…
Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer
OBJECTIVES: We aimed to examine the association between homologous recombination repair (HRR)-related gene mutations and efficacy of oxaliplatin-based chemotherapy in patients with pancreatic ductal adenocarcinoma (PDAC). RESULTS: Non-synonymous mutations in HRR-related genes were found in 13 patien...
Autores principales: | Kondo, Tomohiro, Kanai, Masashi, Kou, Tadayuki, Sakuma, Tomohiro, Mochizuki, Hiroaki, Kamada, Mayumi, Nakatsui, Masahiko, Uza, Norimitsu, Kodama, Yuzo, Masui, Toshihiko, Takaori, Kyoichi, Matsumoto, Shigemi, Miyake, Hidehiko, Okuno, Yasushi, Muto, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929428/ https://www.ncbi.nlm.nih.gov/pubmed/29731985 http://dx.doi.org/10.18632/oncotarget.24865 |
Ejemplares similares
-
Clinical sequencing using a next‐generation sequencing‐based multiplex gene assay in patients with advanced solid tumors
por: Kou, Tadayuki, et al.
Publicado: (2017) -
Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
por: Xue, Peng, et al.
Publicado: (2014) -
Inter-assay variability of next-generation sequencing-based gene panels
por: Quy, Pham Nguyen, et al.
Publicado: (2022) -
Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report
por: Eso, Yuji, et al.
Publicado: (2017) -
Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing
por: Yamamoto, Yoshihiro, et al.
Publicado: (2019)